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The metabolism of arachidonic acid and 1%HPETE was studied in a human promyelo~ytic ell line (HL- 
60). Upon exposure to DMSO, HL-60 cells undergo differentiation and acquire a 15lipoxygenase activity 
while undifferentiated cells challenged with either arachidonic acid or 1%HPETE did not enzymatically 
transform these precursors. Products of the arachidonic acid 15-lipoxygenase pathway were identified by 
HPLC. UV-absorption and gas chromatography-mass pectrometry. Results indicate that upon differentia- 
tion HL-60 cells express a 15-lipoxygenase activity as well as the ability to transform 15HPETE to 8.15- 
DHETEs and 14,15-DHETE. Moreover, these tindings suggest hat products of the 15-lipoxygenase cas- 
cade may be generated by a single cell system. 
Aruchidonic acid Leukotriene 15-Lipoqgenase pathway 
1. INTRODUCTION 
In recent years the metabolism of arachidonic 
acid in human polymorphonuclear leukocytes 
(PMNL) to biologically active derivatives has been 
extensively studied [l]. In human leukocytes, 
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~~~~ev~~~~o~s~ 15-HPETE, ~S(~-hydroperoxy-5,8,1 I  
13-eicosatetraenoic a id; IW-IETE, 15(S)-hydroxy-5,8, 
11,13-eicosatetraenoic acid; 5-HETE, S(S)-hydroxy- 
6,8,11,14-eicasatetraenoic acid; 12HETE, 12(S)-hydro- 
xy-5,8,10,14-eicosatetraenoic a id; LT&, 5(s), 12(R)- 
dihydroxy-6,14-cis-8, IO-trans-eicosatetraenoic acid; 
8,15-DHETE, 8,15(~-dihydroxy-5,9,11,13-eicosatet- 
raenoic acid; 14,15-DHETE, 14~R),l5(~-dihydroxy- 
5,8,10,12-eicosatetraenoic a id; DMSO, dimethyl sulf- 
oxide; GC-MS, gas chromatography-mass pectrometry; 
RP-HPLC, reverse-phase high-performance liquid chro- 
matography; O;-, superoxide ion 
arachidonic acid is metabolized via initial lipox- 
ygenation at either the C-5, C-12 or C-15 position 
giving rise to leukotrienes as well as several other 
mono-, di- and trihydroxy acids [1,21]. 
The human promyelocytic cell-line HL-60, first 
established by Collins et al. in 1977 [2], has been 
shown to possess distinct morphological and 
histochemical characteristics towards myeloid dif- 
ferentiation. Upon exposure to certain polar com- 
pounds (i.e., dimethyl sulfoxide) this cell line 
undergoes differentiation and becomes capable of 
most PMNL functions. These include chemotaxis, 
phagocytosis, respiratory burst activity as well as 
bacterial killing [4-61. Differentiated HL-60 cells 
possess both cycle-oxygenase and lipoxygenase 
functions, as demonstrated by the conversion of 
arachidonic acid to LTB4, S-HETE and thrombox- 
ane [3,18]. 
Here we present evidence indicating that dif- 
ferentiated HL-60 cells also metabolize arachido- 
nit acid via initial lipoxygenation at the C- 15 posi- 
tion to produce 1%HETE as well as 8,lSDHETEs 
and 14,l SDHETE. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Arachidonic acid was purchased from Nu-Chek 
Prep (Elysian, MN) and soybean lipoxygenase 
from Sigma (St. Louis, MO). HPLC equipment 
was from Waters Associated (Milford, MA: pump 
6000-A,‘injector U6K) and from LDC, Laboratory 
Data Control (Riviera Beach, FL: UV-detector 
LDC III). HPLC solvents were purchased from 
Rathburn Chemicals, Walkerburn, Scotland. 
UV detector was set at 270 nm for monitoring of 
conjugated trienes and at 234 nm for conjugated 
dienes. Separation was achieved using a Polygosil 
C-18, 5 pm particle column (0.46 x 35 cm) using 
methanol/water/acetic acid (70 : 30 : 0.01) as a 
mobile phase, at 1 ml/min. Material eluted from 
HPLC chromatograms were coIlected, concen- 
trated and further analyzed by UV spectrometry 
and GC-MS. 
2.5. U V spectrometry 
2.2. Cell preparation 
HL-60 cells, generously provided by Dr R.C. 
Gallo (National Cancer Institute, Bethesda, MD) 
were kept in continuous suspension culture using 
RPMI-1640 medium (GIBCO) supplemented with 
15% heat-jnactivated fetal calf serum, penicillin 
(50 units/ml) and streptomycin (50pglml) as in 
[2]. Differentiation was induced by addition of 
DMSO to a final concentration of 1.3% for 6 days. 
UV spectra were measured with a Hewlett- 
Packard 8450A spectrophotometer with methanol 
as a solvent. Spectra were recorded between 220 
and 320 nm. 
2.6. GC-MS 
Cells cultured in the presence or absence of 
DMSO (6 days) were harvested by centrifugation, 
washed 3 times in phosphate-buffered saline (pH 
7.45), counted, and resuspended at a concentration 
of 30 x IO6 cells/ml in phosphate-buffered saline 
(pH 7.45). 
Samples co-chromatographing with known 
standards of 8, IS-DHETE and 14,15-DHETE 
were treated with diazomethane and converted to 
trimethylsilyl ethers using pyridine, hexamethyl- 
disilazane and trimethylchlorosilane. Samples were 
dried under argon, dissolved in n-hexane and in- 
jected into the GC-MS. The instrument (LKB 
9000) was equipped with a 1% SE-30 column. The 
ionization beam was set at 22.5 eV. 
2.3. rnc~batio~ conditions 
3. RESULTS 
Cell suspensions were warmed for 10 min at 
37°C and then exposed to either arachidonic acid 
(80pM) or 15-HPETE (SOpM) dissolved in 
ethanol. The concentration of ethanol did not ex- 
ceed 0.05% of the incubation mixture. In all ex- 
periments the duration of incubations was 30 min. 
Incubations were carried out in a water bath at 
37°C with gentle continuous stirring. In a typical 
experiment approx. 50- 100 ml of cells at a concen- 
tration of 30 x IO6 cells/ml were used. 
2.4. Extraction and purification 
Incubations of undifferentiated HL-60 cells with 
arachidonic acid did not lead to the formation of 
detectable amounts of products associated with 
either the 5- or 15Jipoxygenase catalyzed reac- 
tions. When differentiated cells (i.e., cells exposed 
to DMSO at a concentration of 1.3% for 6 days) 
were incubated with arachidonic acid under the 
same conditions, several monohydroxy acids were 
produced (fig.l). The identities of these com- 
pounds were established by UV spectrometry and 
co-chromatography with reference compounds 
(i.e., 5-HETE, 12-HETE and I5-HETE [7,20]). 
Incubations were terminated by rapid addition RP-HPLC analysis of material eluting in the 
of 2 vols methanol. Following centrifugation and ethyl acetate fractions (obtained from incubations 
acidification to pH 3 with samples were immedi- with differentiated cells challenged with arachido- 
ately extracted with diethyl ether, evaporated and nit acid) revealed the presence of compounds 
subjected to silicic acid chromatography [8]. Brief- which had retention times characteristic of those of 
ly, ethyl acetate and diethyl ether/n-hexane 8,15-DHETE isomers as well as material with a 
(40: 60) fractions from silicic acid chromatography retention time in accordance with 14,15-DHETE. 
(CC-4, Mallinckrodt, St. Louis, MO) were concen- UV spectrometry of these fractions showed triple 
trated and directly analyzed by RP-HPLC. The peak configurations with a h,,, of 268 nm for the 
15 
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Fig. 1. RP-HPLC chromatogram of monohydroxy acids 
obtained from incubations of differentiated HL-60 cells 
with arachidonic acid. 50 ml of cells (30 x IO6 ceIls/mf) 
in PBS were incubated with arachidonic acid (80 FM) for 
30 min. 40 : 60 diethyl ether/n-hexane fraction from 
silicic acid chromatography was injected on a Polygosil 
C-18, 5 pm column using methanol/water/acetic acid 
(~:40:0.01) as a mobife phase. Detector setting was 
234 nm and pump fIow rate 1 mllmin. Peak A 
represents 15HETE, B corresponds to I2-HETE and C 
to 5-HETE as determined by co-chromatography with 
standards of proven identity. 
two former compounds and a h,,, of 272 nm for 
the latter. 
Human PMNL are capable of converting 15 
HPETE into mono-, di- and trihydroxy acids 
[9,21]. To obtain larger amounts of the dihydroxy 
acids formed by HL-60 cells we next examined the 
metabolism of 15-HPETE in this cell line. Undif- 
ferentiated HL-60 cells exposed to IS-HPETE did 
not convert this substrate into appreciable 
amounts of 14,15DHETE. With differentiated 
cells, however, a pattern very similar to that of in- 
cubations with arachidonic acid and differentiated 
cells was observed (fig.2). Compounds A and B 
gave essentially identical retention times values and 
UV absorption spectra as the compounds obtained 
from incubations with arachidonic acid and dif- 
ferentiated HL-60 cells. These compounds were 
further analyzed by GC-MS. The mass spectra of 
compounds A and B were virtually identical with 
prominent ions at m/e 494, 479, 463, 423, 404, 
394, 353, 321, 263, 237, 217, 199, 191, 173, and 
20 io ’ cj 
Time (mln) 
Fig.2. RP-HPLC chromatogram of products obtained 
from incubation of differentiated HL-60 cells with 
IS-HPETE. 50 ml of cells (30 x LO6 cells/ml) suspended 
in PBS (pH 7.4) were incubated with 1%HPETE to a 
final concentration of 80 x 10e6 M. The ether extract 
was purified by silicic acid column chromatography 
prior to RP-HPLC. Mobile phase was methanol/water/ 
acetic acid (70:3O:O.Oi), flow rate 1 miimin and 
detector setting 270 nm. 
129. The C values of the compounds were 22.3 and 
24.8, respectively (SE-30). These findings suggest 
that compounds A and B are identical to the pair 
of C-8 epimers of 8,15DHETEs [9]. CC-MS 
analysis of compound C revealed two isomers on 
CC. Their respective C values (SE-30) were 23.8 
and 24.7. Both isomers proved to have similar 
mass spectra, with prominent ions at m/e 479,394, 
321, and 173 (fig.3). This is in accordance with 
previously published data for formation of 14,15- 
DHETE by suspensions of human PMNL [9]. 
The transformation was also examined of 
15HPETE (1~~M) incubated with fetal calf 
serum (15%, v/v) in PBS (30 min, 37’C). Here 
conversion of 15HPETE to I4,15-DHETE was 
not observed. Under these conditions, however, 
15-HPETE was converted to 8,15-DHETEs. The 
conversion of 15-HPETE to 8,15DHETEs in fetal 
calf serum most likely proceeds via mechanisms 
similar to those recently observed for the interac- 
tions of hydroperoxy acids and heme-containing 
proteins [ 121. 
16 
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Fig.3. Mass spectrum of compound C from fig.2. Mass spectrum representative of the second isomer appearing on GC 
(SE-30, 1% on S~~eI~o~ort) with a C vdue of 24.7. Prior to injection on CC-MS samples were treared with 
diazomethane in ether and then converted to trimethy~siiyl ether derivatives ( ee section 2). 
4. DISCUSSION 
The studies presented above demonstrate the 
formation of arachidonic acid products associated 
with the 154ipoxygenase pathway by differentiated 
HL-60 cells. This cell line has been kept in con- 
tinuous suspension culture and undergoes myeioid 
differentiation [Z] f Previous studies have shown 
that upon differentiation these cells develop most 
functional responses of human leukocytes [4-61. 
When exposed to the chemotactic peptide, N- 
formyl-Nle-Leu-Phe-Nle-Tyr-Lys, HL-60 cells 
metabolize endogenous sources of arachidonic 
acid and form 5-HETE, 1ZHETE and LTB, [IS]. 
This study [18] ctearly shows the appearance of a 
5lipoxygenase and a 12lipoxygenase activity in 
the differentiated HL-60 cell. In accordance with 
these findings ]lS] we have also observed the for- 
mation of S-HETE, IZHETE and LT%. On the 
basis of the present study it is eiear that upon dif- 
ferentiation HL-60 cells atso acquire a 15-h- 
poxygenase activity and are capable of generating 
compounds which have previously been isolated 
from mixed leukocyte preparations ]9]. 
Since the HL-SO cell line is of cancerous origin, 
it must be taken into consideration that the present 
findings may reflect fundamental abnormalities of 
the cell line. Nevertheless, in view of previous find- 
ings regarding restitution of leukocyte functions 
it is possible that the appearance of a 15-h- 
poxygenase activity during maturation represents 
part of the restitution of leukocyte function {i.e., 
Oi-, degranulation). 
The biological activities of compounds derived 
via the 15-hpoxygenase cascade have recently been 
examined in several systems. It has been shown 
that 14,15-DHETE inhibits NK cefl cytotoxicity, 
thereby suggesting a possible immune regulating 
function for 15lipoxygenase derived eicosanoids 
[ 111. Furthermore, 14,15-DHETE inhibits LTB4- 
induced superoxide anion generation fI4]. How- 
ever, severa isomers of 8, t 5-DHETEs were found 
to be completely inactive when tested for NK cell 
cytotoxicity, human leukocyte aggregation, 
degranulation, and generation of Oi- [11,22]. 
From the present results it is clear that the for- 
mation of I5-iip~xygenase-derived arachidonate 
metabohtes has arisen in HL-60 cells without the 
contribution of other cell types (i.e., RBC, 
platelets, etc.). Maas and Brash [ 191 have proposed 
a mechanism for generation of 14,15-DHETE 
from 15-HPETE involving a 12-lipoxygenase. 
However, since the HL-60 cell line contains both a 
12lipoxygenase and a 15-Iipoxygenase activity, it 
is not possible to conclude on the basis of the pre- 
sent study whether the 14,15-DHETE observed is 
derived from double dioxygenation of 15-HPETE 
or from the formation of an allylic epoxide in- 
termediate (cf. [9,i9]). 
Differentiated HL-60 cells also develop a capaci- 
ty to initiate an oxidative burst [4], This ability has 
been shown to parallel increments in NADPH- 
oxidase activity, Also, increased capacity for O;- 
production parallels increments in the levels of 
cytochrome b in these ceils f4]. Formation of the 
pair of C-g epimeric isomers of 8, I5-DHETE can 
be observed upon incubation of IS-HPETE with 
various heme-proteins [12]. Thus, in the present 
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study the contribution of ~eme-proteins to the for- 
mation of 8,115DHETE cannot be ruled out since 
protein synthesis increases during differentiation 
[4] of these cells. 
[6] Fontana, J.A., Wright, D.G., Schiffman, E., 
The biological activities of compounds derived 
via initial oxygenation of arachidonic acid in the 
C-5 position appear to be related to leukocyte ac- 
tivation and inflammation [I]. Human ieukocytes 
challenged with serum-treated zymosan particles 
or crystals of monosodium urate generate LTB4 
and other derivatives from the S-lipoxygenase 
pathway [ 10,16,17]. The rate-limiting step, 
however, for the conversion of arachidonic acid 
via 5, I2- or 15lipoxygenase pathways is at pre- 
sent not fully understood. Continued study of this 
cell line may help elucidating the mechanism 
whereby cells direct the lipoxygenation of 
arachidonic acid in response to various stimuli. 
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